Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.
- Olaso, E.
- Vidal-Vanaclocha, F.
Revista:
Methods in molecular medicine
ISSN: 1543-1894
Año de publicación: 2003
Volumen: 85
Páginas: 79-86
Tipo: Revisión